I.Ceram, a specialist in innovative biocompatible ceramic implants, announces that it has been nominated for the Prix Galien USA in the Startup Medtech section for its new bioceramic implant “the sternal bar SB-SPIC1” loaded with antibiotics. This allows the stabilization of the sternum for patients with comorbidity factors (diabetes, hypertension, etc.) who must undergo rapid surgical recovery after open-heart surgery (coronary bypass, valve surgery, heart transplant, etc.). ). This implant aims to reduce the risk of bone destruction of the sternum and infection of the sternal part during cardiac surgeries.
The Prix Galien honors the medical excellence of tomorrow by distinguishing, each year, exceptional innovations in all areas of health: drugs, medical devices, e-health. Considered the equivalent of the Nobel Prize in biopharmaceutical research, the Prix Galien highlights unique solutions and people who have influenced healthcare through innovation. Six categories are represented: Biotech, Pharma, MedTech, Digital Health, Incubators and Startups.